is extraordinarily safe—0.1% complication rate across 8 studies representing approximately 900 patients[7][8][9][10][11][12][13][14][15][16] delivers consistent, significant, lasting symptom improvement[7][8][9][10][11][12][14][16] is effective for treatment of patients with chronic or recurrent sinusitis, patients with frontal, maxillary and sphenoid disease, and patients with or without allergies, asthma, septal deviations, and previous surgery[7][8][9][10] can be performed comfortably and effectively under local anesthesia in an office setting[9][10][11][14]